These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 21141979
1. Antifungal activity of amphotericin B conjugated to carbon nanotubes. Benincasa M, Pacor S, Wu W, Prato M, Bianco A, Gennaro R. ACS Nano; 2011 Jan 25; 5(1):199-208. PubMed ID: 21141979 [Abstract] [Full Text] [Related]
2. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects. Charvalos E, Tzatzarakis MN, Van Bambeke F, Tulkens PM, Tsatsakis AM, Tzanakakis GN, Mingeot-Leclercq MP. J Antimicrob Chemother; 2006 Feb 25; 57(2):236-44. PubMed ID: 16361329 [Abstract] [Full Text] [Related]
3. Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells. Haynes MP, Chong PL, Buckley HR, Pieringer RA. Biochemistry; 1996 Jun 18; 35(24):7983-92. PubMed ID: 8672502 [Abstract] [Full Text] [Related]
6. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Gangadhar KN, Adhikari K, Srichana T. Int J Pharm; 2014 Aug 25; 471(1-2):430-8. PubMed ID: 24907597 [Abstract] [Full Text] [Related]
13. In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cells. Staedtke V, Brähler M, Müller A, Georgieva R, Bauer S, Sternberg N, Voigt A, Lemke A, Keck C, Möschwitzer J, Bäumler H. Small; 2010 Jan 25; 6(1):96-103. PubMed ID: 19882684 [Abstract] [Full Text] [Related]
14. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. Lewis RE, Wiederhold NP, Prince RA, Kontoyiannis DP. J Antimicrob Chemother; 2006 Feb 25; 57(2):288-93. PubMed ID: 16387749 [Abstract] [Full Text] [Related]
15. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells. Reyes E, Cardona J, Prieto A, Bernstein ED, Rodríguez-Zapata M, Pontes MJ, Alvarez-Mon M. J Infect Dis; 2000 Jun 25; 181(6):2003-10. PubMed ID: 10837182 [Abstract] [Full Text] [Related]
16. Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME). Szlinder-Richert J, Cybulska B, Grzybowska J, Borowski E, Prasad R. Acta Biochim Pol; 2000 Jun 25; 47(1):133-40. PubMed ID: 10961686 [Abstract] [Full Text] [Related]
18. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B. Paquet V, Volmer AA, Carreira EM. Chemistry; 2008 Jun 25; 14(8):2465-81. PubMed ID: 18196508 [Abstract] [Full Text] [Related]